Literature DB >> 20173672

Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis.

Jing Wen1, Jeong Youp Park, Kyung Hwa Park, Hye Won Chung, Seungmin Bang, Seung Woo Park, Si Young Song.   

Abstract

OBJECTIVE: To characterize the role of Oct4 and Nanog, two important homeobox transcription factors of embryonic development, in pancreatic carcinogenesis.
METHODS: Using a tissue microarray of human pancreatic carcinoma and adjacent noncancerous tissues as well as the N-nitrosobis(2-oxopropyl)amine-induced Syrian golden hamster pancreatic cancer model, we characterized the expression of Oct4 and Nanog. The presence of K-ras mutation with the time course of carcinogenesis in hamster model was also evaluated.
RESULTS: Oct4 expression in metaplastic ducts was significantly stronger than in normal acini and pancreatic carcinoma (P < 0.05). Of 24 cases, 19 (79.2%) showed a strong Oct4 expression in metaplastic ducts. In contrast, only 6 (19.4%) of 31 cancer tissues and 3 (16.7%) of 18 noncancer tissues showed a strong Oct4 expression. Nanog also showed similar patterns as Oct4. Restriction fragment length polymorphism-polymerase chain reaction showed the overt K-ras mutation after the expression of Oct4 in the hamster model.
CONCLUSIONS: The strong expression of Oct4 and Nanog in metaplastic ducts and Oct4 expression preceding Ras mutation suggests that these homeobox transcription factors are associated with the early stage of pancreatic cancer carcinogenesis and may play an important role in that process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173672     DOI: 10.1097/MPA.0b013e3181c75f5e

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  57 in total

1.  Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells.

Authors:  Aurelie Borrull; Stephanie Ghislin; Frederique Deshayes; Jessica Lauriol; Catherine Alcaide-Loridan; Sandrine Middendorp
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-11       Impact factor: 4.553

2.  Hedgehog controls neural stem cells through p53-independent regulation of Nanog.

Authors:  Agnese Po; Elisabetta Ferretti; Evelina Miele; Enrico De Smaele; Arianna Paganelli; Gianluca Canettieri; Sonia Coni; Lucia Di Marcotullio; Mauro Biffoni; Luca Massimi; Concezio Di Rocco; Isabella Screpanti; Alberto Gulino
Journal:  EMBO J       Date:  2010-06-25       Impact factor: 11.598

3.  Identification and manipulation of biliary metaplasia in pancreatic tumors.

Authors:  Kathleen E Delgiorno; Jason C Hall; Kenneth K Takeuchi; Fong Cheng Pan; Christopher J Halbrook; M Kay Washington; Kenneth P Olive; Jason R Spence; Bence Sipos; Christopher V E Wright; James M Wells; Howard C Crawford
Journal:  Gastroenterology       Date:  2013-08-30       Impact factor: 22.682

4.  MiR-335 functions as a tumor suppressor in pancreatic cancer by targeting OCT4.

Authors:  Ling Gao; Yijin Yang; Haiyan Xu; Ruqian Liu; Dechun Li; Han Hong; Mingde Qin; Yunliang Wang
Journal:  Tumour Biol       Date:  2014-05-24

Review 5.  Inducing iPSCs to escape the dish.

Authors:  Bonnie Barrilleaux; Paul S Knoepfler
Journal:  Cell Stem Cell       Date:  2011-08-05       Impact factor: 24.633

6.  CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide.

Authors:  Sulagna Banerjee; Alice Nomura; Veena Sangwan; Rohit Chugh; Vikas Dudeja; Selwyn M Vickers; Ashok Saluja
Journal:  Clin Cancer Res       Date:  2014-03-14       Impact factor: 12.531

7.  Clinical significance of the stem cell gene Oct-4 in cervical cancer.

Authors:  Yanyan Yang; Yimin Wang; Chunxia Yin; Xiuying Li
Journal:  Tumour Biol       Date:  2014-02-16

8.  Oct4-Mediated Inhibition of Lsd1 Activity Promotes the Active and Primed State of Pluripotency Enhancers.

Authors:  Lama AlAbdi; Debapriya Saha; Ming He; Mohd Saleem Dar; Sagar M Utturkar; Putu Ayu Sudyanti; Stephen McCune; Brice H Spears; James A Breedlove; Nadia A Lanman; Humaira Gowher
Journal:  Cell Rep       Date:  2020-02-04       Impact factor: 9.423

9.  OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells.

Authors:  Malek Hossein Asadi; Khosrow Khalifeh; Seyed Javad Mowla
Journal:  J Neurooncol       Date:  2016-09-01       Impact factor: 4.130

Review 10.  New insights into pancreatic cancer stem cells.

Authors:  Chinthalapally V Rao; Altaf Mohammed
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.